arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MetaVia Inc.

MTVA
$1.47 ▼ -0.02 (-1.34%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
13 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

MetaVia Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.6M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -257.0%
FCF / Share $-8.89
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-12.97M
↑ +53.0%
FCF / Share Free cash flow per share
$-8.89
↑ +74.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
1
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 46 quarters